Helsinn Healthcare SA Announces The Launch Of Aloxi(R) (Palo

LUGANO, Switzerland, February 11 /PRNewswire/ -- Helsinn Healthcare SA, a Swiss pharmaceutical group, is pleased to announce, ahead of schedule, today's launch in the UK of Aloxi(R) (Palonosetron hydrochloride), a new generation treatment for chemotherapy, induced nausea and vomiting, by its local partner Maelor plc, the specialist hospital medicin

Related Keywords

United Kingdom , Switzerland , United States , Lugano , Ticino , Swiss , Tim Wright , Cryogesicr Dermogesic , Paolo Ferrari , Matthew Hall Sam Reynolds , Aloxir Palonosetron , Billy Clegg Edward Westropp , Riccardo Braglia , Cr Bard Inc , Noble Company , Optiflo Tm Catheter Maintenance Solutions , Financial Dynamics Limited Tel , Financial Dynamics , Plethora Solutions , Helsinn Healthcare , Alternative Investment Market , Essential Tremor , Catheter Maintenance Solutions , Bard Limited , Micelle Nanotechnology , Plethora Solutions Limited , Active Pharmaceutical Ingredients , High Potency Active Ingredients , Financial Dynamics Limited , Edward Westropp , Company Limited , Sam Reynolds , Supportive Care , Billy Clegg , Matthew Hall , Cancer Research ,